In December 2025, the World Health Organization (WHO) issued guidelines explicitly recommending that obese adults (excluding pregnant women) consider telatopeptide as a long-term treatment option, but this must be combined with a healthy diet, exercise, and professional guidance. This type of medication has been included in the 2025 Essential Medicines List for the management of high-risk groups for type 2 diabetes.
While weight loss through medication continues to be a topic of discussion, experts remind us that there is no magic bullet for weight loss, nor are there any shortcuts. Changing lifestyle and establishing healthy eating and behavioral habits are the foundation of all weight loss efforts.